Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

Summary

This prospective annual release study is designed to evaluate the safety of 1 new influenza virus vaccine strain to be included in FluMist Quadrivalent for the 2017-2018 influenza season.

Timeline

Start

2017-05-30

Primary completion

2017-12-14

Completion

2017-12-14

Outcome

Missed primary endpoint

registry analysis (superiority test); Monovalent Influenza Vaccine vs Placebo; Rate difference 0 (95% CI -6.7 to 1.9) NCT03158038 ↗

Drugs

Indications